BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,224,101 | -64.9% | 106,629 | -61.5% | 0.06% | -68.8% |
| Q3 2022 | $3,486,000 | -9.5% | 276,629 | -24.1% | 0.20% | -9.8% |
| Q2 2022 | $3,854,000 | +25.4% | 364,252 | -11.7% | 0.22% | +100.0% |
| Q4 2020 | $3,073,000 | +6.7% | 412,419 | -50.8% | 0.11% | -24.8% |
| Q3 2020 | $2,881,000 | +38.5% | 838,719 | +92.1% | 0.15% | -25.5% |
| Q2 2020 | $2,080,000 | -72.3% | 436,500 | -80.0% | 0.20% | -69.8% |
| Q4 2019 | $7,521,000 | +873.0% | 2,179,950 | +2053.1% | 0.66% | +306.1% |
| Q3 2018 | $773,000 | -1.7% | 101,245 | -32.5% | 0.16% | -29.1% |
| Q3 2017 | $786,000 | +41.4% | 150,000 | +50.0% | 0.23% | +4.1% |
| Q2 2017 | $556,000 | – | 100,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 864,916 | $13,674,000 | 13.71% |
| Sarissa Capital Management LP | 4,261,000 | $67,366,000 | 5.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $30,367,000 | 4.18% |
| HealthCor Management, L.P. | 3,248,100 | $51,352,000 | 2.05% |
| Parkman Healthcare Partners LLC | 351,961 | $5,565,000 | 1.22% |
| Bain Capital Public Equity Management II, LLC | 1,560,730 | $24,675,000 | 1.06% |
| Baker Brothers Advisors | 12,710,818 | $200,958,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,835,000 | $44,821,000 | 0.80% |
| Biondo Investment Advisors, LLC | 265,840 | $4,203,000 | 0.72% |
| EAM Global Investors LLC | 157,065 | $2,483,000 | 0.69% |